Navigation Links
Remission in Medical News

Care management reduces depression and suicidal thoughts in older primary care patients

... of patients receiving treatment, lead to a higher remission rate of depression, and reduce suicidal thoughts. ... was 2.2 times greater in the PROSPECT group. remission of depression happened faster in the PROSPECT intervention group and remission rates continued to increase between months 18 and ...

Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal

... timing of treatment withdrawal once a state of remission on medication is achieved. While this holds true ... of MTX for 12 to 24 months after induction of remission has been proposed by researchers.1 The risk of ... that continuing MTX therapy past the point of remission does not affect the risk of relapses after ...

Study IDs benefit of donor SCT for adults with acute myeloid leukemia

... AML patients, allogeneic transplant in first remission proved to be the most effective strategy, the ... significantly from allogeneic transplant in first remission should establish it as the preferred treatment ... stem cell transplants in first clinical remission were more likely to be alive than those who ...

Two Drugs Better Than One for Crohn's Patients

... remission rates higher with combination therapy, study ... likely to have the disease go into steroid-free remission than those who received only one of the drugs, ... of the patients who were in steroid-free remission at week 50 was 46.2 percent with infliximab plus ...

For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission

... identify a therapy's effect on induction of remission as the attribute that most influences their ... Than Infliximab finds that a drug that maintains remission in a higher percentage of patients with moderate ... has potential to be superior in maintenance of remission when compared to infliximab. "Although ...

Nationwide 'GI Nurses & Associates Day' Celebrates Contributions of Gastroenterology and Endoscopy Professionals

... of inflammatory bowel disease, and to maintain remission of UC. Asacol is the number one most-dispensed ... tid for 6 weeks) and for the maintenance of remission of UC (the indicated dosage is 1.6 g/day in ... percent vs. 15 percent); for the maintenance of remission of UC, the most frequent adverse events were ...

New therapy with stem cells to treat Crohn's disease

... successfully in the US and Italy, where total remission of the disease has been shown in 80% of cases, ... of transplant patients are in a phase of total remission of the disease and the remaining 20% have shown ... cells. The immune system is reset, leading to remission or reduction of the abnormal inflammatory process ...

Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease

... a therapy's effect on maintenance of clinical remission is the attribute that most influences their ... Crohn's Disease: Maintenance of Clinical remission is a Key Challenge and a Large Commercial ... Crohn's Disease: Maintenance of Clinical remission is a Key Challenge and a Large Commercial ...

New Study Demonstrates Cost Effectiveness of NeuroStar TMS Therapy(R) in the Treatment of Depression

... had statistically significant response and remission rates, which were approximately twice the rate of ... to 50% improvement in symptoms, and the remission rate is the percentage of patients who achieved ... achieved a 54% response rate and a 33% remission rate on the HAMD 24-item scale, at the end ...

'Multi-target' immune therapy improves outcomes of severe lupus nephritis

... to traditional therapy for inducing complete remission of class V+IV lupus nephritis, with few side ... drug (cyclophosphamide). The complete remission rate, with recovery of normal kidney function, ... receiving multi-target therapy, the complete remission rate reached 65 percent at nine months, versus ...

Long-term safety data on Lialda published in leading GI journal

... of patients on Lialda continued to remain in remission through 12 months." Specifically, the primary ... endpoints of the study evaluated maintenance of remission and relapse rates over 12 months. In the efficacy ... were in strictly defined clinical and endoscopic remission (P=0.351). Thus, there was no significant ...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

... patients on Lialda continued to remain in remission through 12 months." Specifically, the primary ... were in strictly defined clinical and endoscopic remission (P=0.351). Thus, there was no significant ... to strictly defined clinical and endoscopic remission at month 12. Further, 88.9 percent and 93.2 ...

Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis

... microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as ... 4.4 in the validation population). Predicting remission Overall, 6% and 7% of patients in the study ... groups, respectively fell into the disease remission category. The results from the clinical scores in ...

New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

... HUMIRA(R) (adalimumab) resulted in clinical remission among long-standing RA patients when used in ... percentage of patients achieving clinical remission continued to increase after two or more years of ... these studies assessed the measures of efficacy, remission and change over time in the safety profile in ...

50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks

... onset rheumatoid arthritis patients achieve remission (a state free of signs and symptoms) within 36 ... Results of this study indicate that achieving remission is not only possible during clinical trials but ... clinical care. Of 169 early RA patients, remission (defined as DAS28 The researchers achieved ...

Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients

... Over 39 percent of patients achieved remission by six weeks. Data also showed one-third of ... or equal to 100 points from baseline) at Week 6. remission was defined as a CDAI score of less than or equal ... can experience an ongoing cycle of flare-up and remission throughout their lives. Together with ...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

... in 2007 titled "UC: NORMAL (New Observations on remission Management and Lifestyle)." The objectives of ... PENTASA(R) (mesalamine) for the induction of remission and treatment of patients with mild to moderately ... for UC. LIALDA is indicated for the induction of remission in patients with active, mild to moderate UC. ...

Aggressive Therapy for Crohn's Disease Produces Better Outcomes

... International study found remission occurred faster, more often with ... with the disease was more effective in inducing remission than starting patients on corticosteroids, ... in the combined immunosuppression group were in remission without steroids or surgery, compared with 35.9 ...

High-Dose Chemo Helps Beat Rare Brain Cancer

... Many patients achieved long-term remission without radiation, study finds ... that 52 percent of the patients had a complete remission of their cancer and 40 percent had not had a ... that it is unusual for a single drug to achieve remission in cancer. More studies are needed to find ...

VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

... ) "The very high complete and near complete remission rate of 21 percent with this induction therapy significantly improved post-transplantation complete remission rates. This led to a decrease in patients ... cell transplantation (SCT) produced low complete remission rates and offered minimal incremental benefit ...

Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma

... from a donor resulted in long-term complete remission for 45 of 47 patients in a clinical trial, ... cells. At transplantation, 29 were in partial remission and 18 were in complete remission. All 47 achieved complete remission after receiving matched blood stem cells from ...

EpiCept Releases New Data Demonstrating Prolonged Five-Year Leukemia-Free Survival for AML Patients Treated with Ceplene(TM) + IL-2

... + IL-2. The median LFS of AML patients in first remission was 15 months for the Ceplene + IL-2 group versus ... of the overall survival rate in the first remission patient group was 44 months for the Ceplene + ... demonstrated that patients with AML in complete remission who received 18 months of treatment with Ceplene ...

Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma

... achieved a fourfold increase in the complete remission rate. Complete remission is widely recognized as a predictor for long-term ... (SCT), the VcTD arm demonstrated a complete remission (CR, including immunofixation positive and ...

Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives

... for UC. LIALDA is indicated for the induction of remission in patients with active, mild to moderate UC. ... LIALDA tablets are indicated for the induction of remission in patients with active, mild to moderate ... PENTASA is indicated for the induction of remission and for the treatment of patients with mildly to ...

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

... courses of which are characterized by periods of remission and periods of acute flare up, determining ... the cornerstone of therapy for induction of remission in Inflammatory Bowel Disease (IBD); however, the ... clinical efficacy in maintaining long-lasting remission beyond 1 year of treatment. The steroid-sparing ...

New Analyses of long-term LIALDA (mesalamine) data presented at ACG

... is well-tolerated and effective at inducing remission in patients with active, mild to moderate UC. ... provided evidence that LIALDA maintained remission in a variety of UC patients, said Gary R. ... to review the efficacy of LIALDA for maintaining remission in patients with mild versus moderate ulcerative ...

Ethicon Endo-Surgery Holds Metabolic Surgery Scientific Forum Featuring Research By Top Scientists

... as a primary treatment for Type 2 diabetes and presented data on diabetes remission after metabolic surgery even before weight loss occurs. He asserted that remission results from more than gastric restriction and weight loss and that the ...

For Kids With Leukemia, Radiation May Be Safe to Skip

... Hospital found that children who had chemotherapy alone had a longer remission period and experienced fewer adverse events than those who, in the past, ... been treated with prophylactic cranial radiation for ALL. The five-year remission rate for the chemotherapy-only group was 90.8 percent, vs. 73 percent for ...

Weight-Loss Surgery Safe, Effective Type 2 Diabetes Treatment

... Wednesday found that weight-loss surgery can lead to the long-term remission of diabetes. Researchers from Virginia Commonwealth University examined ... on insulin. After five years, about 40 percent of patients were in remission and about 43 percent had improved blood sugar levels. The average fasting ...

Donor Stem-Cell Transplant Best For Acute Myeloid Leukemia

... latest review could lead to a new standard of care. "First complete remission does not mean you are cured. It doesn't mean that you have eradicated ... stem cell transplants -- the donor stem cells -- in first clinical remission were more likely to survive and less likely to suffer a relapse over the ...

Breast-feeding OK for Most Moms with MS

... said that researchers have long known that women with MS often go into remission during pregnancy, which might indicate that hormones play some role in ... to the myelin. However, she said. the study's finding of continued MS remission during breast-feeding would suggest that pregnancy hormones, which ...

New Insights, Inroads Against Breast, Ovarian Cancers

... treatment. For this study, 265 women whose ovarian cancer was in remission after one round of chemotherapy began a second round of chemo as soon as ... that the early initiation of chemotherapy did not induce a longer remission and, despite all this early treatment, did not improve survival." On ...

Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans

... Important Safety Information Lialda is approved for the induction of remission in patients with active, mild to moderate ulcerative colitis. Safety and ... Important Safety Information PENTASA is approved for the induction of remission and for the treatment of mildly to moderately active ulcerative colitis. ...

Vion Pharmaceuticals Reports 2009 First Quarter Results

... (FDA) for its lead anticancer agent Onrigin (laromustine) Injection for remission induction treatment for patients sixty years of age or older with de novo ... The Company has an NDA under review with the FDA for Onrigin for remission induction treatment for patients sixty years of age or older with de novo ...

Are we cherry picking participants for studies of antidepressants?

... criteria for phase III trials had better outcomes, including higher remission rates, less severe side effects and serious adverse events. The depression remission rate in the patients who met the criteria was 34.4 percent, compared to ...

Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)

... 16, 2009. The NDA presents data for Onrigin(TM) as a single agent for remission induction treatment for patients sixty years of age or older with de novo ... The FDA is reviewing a New Drug Application for Onrigin(TM) for remission induction treatment for patients sixty years of age or older with de novo ...

Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA

... in February 2009. The NDA presents data for Onrigin as a single agent for remission induction treatment for patients sixty years of age or older with de novo ... Triapine(R). The FDA is reviewing a New Drug Application for Onrigin for remission induction treatment for patients sixty years of age or older with de novo ...

Patient preferences play role in racial disparities in rheumatoid arthritis treatment

... to commonly used RA drugs. These included benefits such as the chance of remission or symptom improvement, and risks such as side effects and theoretical ... cancer, whereas white patients were most concerned with the likelihood of remission and halting radiographic progression. Until now, it has been widely ...

HIV Experts Propose New Approach to Eradicate HIV in Latest Issue of Science

... together to set a goal for the next era in HIV therapeutics - drug free remission - and assemble a coordinated initiative to identify potential ... therapeutic interventions that can eradicate HIV and result in drug-free remission for HIV patients," said Paul Stoffels, M.D., Company Group Chairman, ...

St. Jude finds more than 100 gene variations linked with response to leukemia treatment

... (MRD). MRD is the small number of leukemic cells that survive after remission induction therapythe initial treatment. This measurement helps clinicians ... might be cured with milder and less-toxic treatment; and also shows if remission induction therapy will likely fail. The researchers performed a search ...
Other Contents
(Date:9/19/2014)... Jimmy Durante of dinosaurs a newly discovered ... new dinosaur, named Rhinorex condrupus by ... Young University, lived in what is now Utah ... Cretaceous period. , Rhinorex, which translates roughly into ... relative of other Cretaceous hadrosaurs like Parasaurolophus and ...
(Date:9/19/2014)... today by researchers from several Harvard University labs ... experienced and aspiring researchers with the intellectual raw ... made from soft, flexible materials. , With the ... other advances in manufacturing technology, soft robotics is ... drawn from conventional rigid robot design, but working ...
(Date:9/19/2014)... the unique bioelectric signaling system of the electric fish, ... The OU researcher is working to understand how these ... used to map the world around them. Electric ... discharges a second throughout their lives. The energetic ... necessary for survival. , "There is evidence that electric ...
Breaking Biology News(10 mins):New hadrosaur noses into spotlight 2Soft robotics 'toolkit' features everything a robot-maker needs 2
(Date:9/19/2014)... human cancers have abnormally upregulated chemical signals related ... controlled during tumor formation is not fully understood. ... PhD, both researchers in the department of Pathology ... Medicine, University of Pennsylvania, and colleagues report that ... by targeting these pathways. , Lipid second messengers ...
(Date:9/19/2014)... Hastings and Hastings, a discount accident lawyer in Phoenix, Arizona, ... number of visitors to its new Phoenix personal injury website. ... as well as auto accident cases and slip & fall ... others. Having served the state of Arizona for over 30 ... when it comes to dedicated and focused personal injury legal ...
(Date:9/19/2014)... Dartmouth researcher, working with The Melanoma Genetics Consortium, GenoMEL, ... in the Journal of the National Cancer Institute ... melanoma. , "For the first time, we have established ... play a part in the risk of developing melanoma," ... School of Medicine at the University of Leeds (UK). ...
(Date:9/19/2014)... Visiting Nurse Association (VNA) Health Group, ... hospice and palliative care and community-based care, was honored ... yesterday at the New York Stock Exchange. , Founded ... entrepreneur to care for immigrant families suffering from tuberculosis ... to meet the urgent healthcare needs of the communities ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 According to ... of the embattled blood-thinner Xarelto, named as defendants in ... Common Pleas, have moved the court to dismiss those ... not have sufficient connection with Philadelphia.* The cases include, ... al. (No. 140304328; Pa. Comm. Pls., Philadelphia Cty.), which ...
Breaking Medicine News(10 mins):Health News:New cancer drug target involving lipid chemical messengers 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Melanoma risk found to have genetic determinant 2Health News:NJ Largest Home Healthcare Not-for-Profit Joins Deutsche Bank to Ring NYSE Opening Bell 2Health News:NJ Largest Home Healthcare Not-for-Profit Joins Deutsche Bank to Ring NYSE Opening Bell 3Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3
Other TagsOther Tags